Genoway SaEURONEXT: ALGEN

Solides résultats semestriels 2025 avec une marge d’EBITDA à 16,9%

Sep 22, 2025 at 4:36 PM UTC · Issued by Genoway Sa

22 Sep 2025 18:23 CEST

Subscribe

Nom de l'emetteur

GENOWAY

genoway-cp-rs-2025-22092025-vdef.pdf

Source

GENOWAY

Fournisseur

Euronext

Company Name

GENOWAY

ISIN

FR0004053510

Symbole

ALGEN

Marché

Euronext Growth

Earlier from Genoway Sa

GenOway: Résultats annuels 2023Mar 27, 2024
GenOway: Résultats du 1er semestre 2023Sep 22, 2023
GenOway: Proposal of a new administratorMay 23, 2022
GENOWAY: A grant for €1.9 million has been awarded under the Eurostars™ programme to a consortium that comprises Abzena, Antitope, Prothix BV, Aristi Biotech BV, the University Medical Center Utrecht, and genOwayJan 28, 2016

All Genoway Sa news releases